| Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
|---|
| 01/10/2013 | US20130011403 Klebsiella antigens |
| 01/10/2013 | US20130011402 Compositions and methods for the diagnosis and treatment of tumor |
| 01/10/2013 | US20130011401 Soluble proteins for use as therapeutics |
| 01/10/2013 | US20130011400 Methods For Inducing Autolysis In Infectious Bacteria |
| 01/10/2013 | US20130011395 Methods and compositions for treating autoimmune diseases or conditions |
| 01/10/2013 | US20130011391 Anti-psgl-1 antibodies and uses thereof |
| 01/10/2013 | US20130011389 Compositions and methods for treating coagulation related disorders |
| 01/10/2013 | US20130011388 Intravenous immunoglobulin composition |
| 01/10/2013 | US20130011386 Active protease-resistant antibody fc mutants |
| 01/10/2013 | CA2844532A1 An antibody inducing antigen-specific t cell tolerance and use thereof |
| 01/10/2013 | CA2841372A1 Agr2 blocking antibody and use thereof |
| 01/10/2013 | CA2841039A1 Multispecific antibodies |
| 01/10/2013 | CA2840711A1 Arginine-free tnfr:fc-fusion polypeptide compositions and methods of use |
| 01/10/2013 | CA2840426A1 Use of anti-cd83 agonist antibodies for treating autoimmune diseases |
| 01/10/2013 | CA2840424A1 Regulatory t cells and methods of identifying, obtaining and using to treat immuno-based disorders |
| 01/10/2013 | CA2840221A1 P97-antibody conjugates and methods of use |
| 01/10/2013 | CA2840147A1 Polypeptide variants and uses thereof |
| 01/10/2013 | CA2840088A1 Antibodies against epidermal growth factor receptor (egfr) and uses thereof |
| 01/10/2013 | CA2839513A1 Therapeutic combinations of anti - cd20 and anti - gm - csf antibodies and uses thereof |
| 01/10/2013 | CA2838695A1 Mammalian cell culture |
| 01/09/2013 | EP2544004A1 Gastric cancer marker, and method for detecting gastric cancer |
| 01/09/2013 | EP2543730A1 Antibody constant region variant |
| 01/09/2013 | EP2543727A1 Modified antibody composition |
| 01/09/2013 | EP2543680A1 Multispecific mutated antibody Fab fragments |
| 01/09/2013 | EP2543679A1 Antibodies for the treatment and prevention of thrombosis |
| 01/09/2013 | EP2543678A1 Antibodies for the treatment and prevention of thrombosis |
| 01/09/2013 | EP2543677A1 Antibodies for the treatment and prevention of thrombosis |
| 01/09/2013 | EP2543389A2 Methods and compositions inhibiting a lysyl oxidase (-like) protein for treatment and diagnosis of fibrosis, tumor invasion, angiogenesis, and metastasis |
| 01/09/2013 | EP2543388A1 Drug for inflammatory bowel disease |
| 01/09/2013 | EP2543383A1 Macrocyclic compounds and methods of treatment |
| 01/09/2013 | EP2542892A2 Prognostic marker for cryoglobulinemic vasculitis and b cell malignancies in hcv infected patients |
| 01/09/2013 | EP2542686A1 Compositions and methods for bacterial production of chondroitin |
| 01/09/2013 | EP2542590A2 Compositions and methods for targeted immunomodulatory antibodies and fusion proteins |
| 01/09/2013 | EP2542589A1 Anti-her2 antibodies and compositions |
| 01/09/2013 | EP2542588A1 Antibodies against human csf-1r and uses thereof |
| 01/09/2013 | EP2542587A1 Antibodies against human csf-1r and uses thereof |
| 01/09/2013 | EP2542586A1 Naturally occurring autoantibodies against alpha-synuclein that inhibit the aggregation and cytotoxicity of alpha-synuclein |
| 01/09/2013 | EP2542585A2 Methods for treating colorectal cancer |
| 01/09/2013 | EP2542584A2 Methods for treating pancreatic cancer |
| 01/09/2013 | EP2542583A2 Methods for treating breast cancer |
| 01/09/2013 | EP2542582A2 Therapeutic dll4 binding proteins |
| 01/09/2013 | EP2542581A1 Antibody specific for apolipoprotein and methods of use thereof |
| 01/09/2013 | EP2542580A1 Antibodies against phosphorylcholine in combination therapy with biologic agents |
| 01/09/2013 | EP2542579A1 Biparatopic abeta binding polypeptides |
| 01/09/2013 | EP2542578A1 Smoc1, tenascin-c and brain cancers |
| 01/09/2013 | EP2542577A1 Improved therapeutic antibodies against flagellated pseudomonas aeruginosa |
| 01/09/2013 | EP2542576A1 Methods for screening antibodies |
| 01/09/2013 | EP2542575A1 Expression of monoclonal antibodies in ciliate host cells |
| 01/09/2013 | EP2542573A1 Novel protein with structural homology to proteins with il-8-like chemokine fold and uses thereof |
| 01/09/2013 | EP2542571A1 Oligomer-specific amyloid beta epitope and antibodies |
| 01/09/2013 | EP2542570A1 Target of egr1 (toe1 ) polypeptides for inhibition of hiv |
| 01/09/2013 | EP2542566A2 Molecular clone of hiv-1 |
| 01/09/2013 | EP2542262A1 Monoclonal antibodies directed to cd20 |
| 01/09/2013 | EP2542261A1 Antigen binding proteins specific for serum amyloid p component |
| 01/09/2013 | EP2542258A1 Monoclonal antibodies directed to cd52 |
| 01/09/2013 | EP2542257A1 Optimized monoclonal antibodies against tissue factor pathway inhibitor (tfpi) |
| 01/09/2013 | EP2542256A2 Antibodies reactive with b7-h3, immunologically active fragments thereof and uses thereof |
| 01/09/2013 | EP2542255A1 Methods and compositions for treating degos' disease |
| 01/09/2013 | EP2542221A2 Concentrated protein formulations and uses thereof |
| 01/09/2013 | EP2182981B1 Methods and compositions for treatment and diagnosis of fibrosis |
| 01/09/2013 | CN102869682A Monoclonal antibodies and diagnostic uses thereof |
| 01/09/2013 | CN102869681A Immunoassay for chromogranin A, antibodies and kit |
| 01/09/2013 | CN102869680A Protofibril-binding antibodies and their use in therapeutic and diagnostic methods for parkinson's disease, dementia with lewy bodies and other alpha-synucleinopathies |
| 01/09/2013 | CN102869673A Antifreeze protein |
| 01/09/2013 | CN102863533A Method for reforming antibody in humanized way |
| 01/09/2013 | CN102863532A Interferon alpha receptor 1 antibodies and their uses |
| 01/09/2013 | CN102863531A CD20-resistant monoclonal antibody as well as preparation method and application thereof |
| 01/09/2013 | CN102863530A Fat cell differentiation metabolite IGF-1 antibody, chip including same and application of fat cell differentiation metabolite IGF-1 antibody |
| 01/09/2013 | CN102863529A VEGF (vascular endothelial growth factor) monoclonal antibody and fracture healing evaluation antibody chip with same |
| 01/09/2013 | CN102863528A Bovine-derived anti-staphylococcus aureus single-chain antibody, preparation method and application thereof |
| 01/09/2013 | CN102863527A Humanized hepatitis b virus resistance surface antigen gene engineering antibodies and preparation method and application thereof |
| 01/09/2013 | CN102861333A High-activity composite antibody oral preparation for resisting bursa fabricius viruses and influenza viruses of chicken |
| 01/09/2013 | CN102861327A Cell inactivated vaccine, egg yoke antibody and injection and freeze-dried powder containing same |
| 01/09/2013 | CN102861325A Compositions for reducing bacterial carriage and cns invasion and methods of using same |
| 01/09/2013 | CN102861319A Methods of modulating immune responses by modulating tim-1, tim-2 and tim-4 function |
| 01/09/2013 | CN102329393B Monoclonal antibody resisting Abeta (beta-amyloid) 42 peptide and application thereof |
| 01/09/2013 | CN102212135B Anti-vascular endothelial growth factor monoclonal antibody and application thereof |
| 01/09/2013 | CN102174474B Sildenafil monoclonal antibody and colloidal gold chromatography test strip used for detecting sildenafil |
| 01/09/2013 | CN102140139B Antitumor human single-chain antibody |
| 01/09/2013 | CN101936985B Method for detecting diethylstilbestrol and special chemiluminescent immunoassay kit thereof |
| 01/09/2013 | CN101935349B Humanized monoclonal antibody against human vascular endothelial growth factor and preparation and application thereof |
| 01/09/2013 | CN101591396B Anti-erbB2 human antibody MIL-5 and application thereof |
| 01/09/2013 | CN101218255B 抗gm-csf抗体和其用途 Anti-gm-csf antibodies and uses thereof |
| 01/08/2013 | US8350017 Poly-N-acetyl glucosamine (PNAG/dPNAG)-binding peptides and methods of use thereof |
| 01/08/2013 | US8350012 Inverse agonist monoclonal antibody that suppresses thyrotropin receptor constitutive activity |
| 01/08/2013 | US8350011 Antibodies to ErbB2 |
| 01/08/2013 | US8350010 Anti-alpha5/beta1 antibody |
| 01/08/2013 | US8350009 exhibits tissue specific expression in normal adult tissue, and is aberrantly expressed in the cancers; diagnostic, prognostic, prophylactic and/or therapeutic target for cancer; biomarkers |
| 01/08/2013 | US8350008 WISP polypeptides and nucleic acids encoding same |
| 01/08/2013 | US8349805 Use of Gonadorelin as a therapeutic agent |
| 01/08/2013 | US8349791 Polypeptides that bind membrane proteins |
| 01/08/2013 | US8349569 Anti-fibronectin fragment monoclonal antibody |
| 01/08/2013 | US8349336 Streptococcus pyogenes antigens |
| 01/08/2013 | US8349332 Multiple signaling pathways induced by hexavalent, monospecific and bispecific antibodies for enhanced toxicity to B-cell lymphomas and other diseases |
| 01/08/2013 | US8349331 Anti-interferon-α antibodies |
| 01/08/2013 | US8349330 Therapeutic use of anti-CS1 antibodies |
| 01/08/2013 | US8349328 Rodent control agents comprising antibodies that binds to rodent specific peptide epitopes |
| 01/08/2013 | US8349326 Methods and systems for multi-antibody therapies |
| 01/08/2013 | US8349325 Soluble FMS-like tyrosine kinase-1 (sFLT-1) antibody and related composition, kit, methods of using, and materials and method for making |
| 01/08/2013 | US8349323 Cytokine antagonists for neurological and neuropsychiatric disorders |